Reply To: Detection of Alpha-Synuclein in Saliva: The Importance of Preanalytical Assessment

Affiliations

¹ Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, New York, USA.
² BioLegend Inc., Dedham, Massachusetts, USA.
³ The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
⁴ Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

Comment

Un Jung Kang et al. Mov Disord. 2018 Jul.

. 2018 Jul;33(6):1031.

doi: 10.1002/mds.27424.

¹ Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, New York, USA.
² BioLegend Inc., Dedham, Massachusetts, USA.
³ The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
⁴ Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.

No abstract available

Keywords: Parkinson's disease; alpha-synuclein; saliva.

Comment on

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K; Fox Investigation of New Biomarker Discovery; Kang UJ. Goldman JG, et al. Mov Disord. 2018 Feb;33(2):282-288. doi: 10.1002/mds.27232. Epub 2017 Dec 4. Mov Disord. 2018. PMID: 29205509 Free PMC article.
Detection of α-Synuclein in Saliva: The Importance of Preanalytical Assessment.
Vivacqua G, Mancinelli R, Belvisi D, Suppa A, Berardelli A. Vivacqua G, et al. Mov Disord. 2018 Jul;33(6):1029-1030. doi: 10.1002/mds.27423. Mov Disord. 2018. PMID: 30134054 No abstract available.